Clareo Health | Effectiveness of Video-Based Movement Analysis-Guided Personalized Rehabilitation in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seoul National University Bundang Hospital
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients aged 19 years or older.
Diagnosed with breast cancer, colorectal cancer, or gynecological cancer, and currently receiving chemotherapy or under follow-up observation after completing treatment.
History of treatment with neurotoxic chemotherapeutic agents (e.g., taxane, platinum, etc.) or experiencing related symptoms.
Symptoms or risk of chemotherapy-induced peripheral neuropathy (CIPN) (NCI-CTCAE Grade \>= 1).
Able to walk independently (with or without assistive devices).
Able to understand the study purpose and procedures and voluntarily provide written informed consent.
You may not be if
Peripheral neuropathy clearly attributable to causes other than CIPN, such as diabetic neuropathy.
Severe central nervous system disorders (e.g., stroke, Parkinson's disease, etc.) or severe musculoskeletal disorders that make functional assessment or exercise performance difficult.
Severe cognitive impairment that interferes with study participation or the ability to follow instructions.
Recent significant injury due to a fall, or cases where exercise performance is deemed medically unsafe.
Recurrent or progressive cancer with an unstable general systemic condition.
Any other condition or clinical reason that, in the opinion of the investigator, makes participation in the study inappropriate.
